{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:47:23Z","timestamp":1771526843281,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"NA","award":["This work was supported by AIBILI"],"award-info":[{"award-number":["This work was supported by AIBILI"]}]},{"name":"NA","award":["by NextGenerationEU (PRR - Financiamento Base - Centros de Tecnologia e Inova\u00e7\u00e3o - Investimento RE-C05-i02 - Miss\u00e3o Interface n\u00ba 03\/C05-i02\/2022)."],"award-info":[{"award-number":["by NextGenerationEU (PRR - Financiamento Base - Centros de Tecnologia e Inova\u00e7\u00e3o - Investimento RE-C05-i02 - Miss\u00e3o Interface n\u00ba 03\/C05-i02\/2022)."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40123-025-01179-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:54:23Z","timestamp":1751374463000},"page":"1905-1915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Microaneurysm Counting as a Biomarker for the Hyperperfusion Stage of Nonproliferative Diabetic Retinopathy"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-3604","authenticated-orcid":false,"given":"Lu\u00eds","family":"Mendes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9014-0362","authenticated-orcid":false,"given":"Ana","family":"Rocha","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-8499","authenticated-orcid":false,"given":"Marta","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-8729","authenticated-orcid":false,"given":"Ana","family":"Almeida","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-0957","authenticated-orcid":false,"given":"Nicole","family":"Duarte","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8769-1355","authenticated-orcid":false,"given":"D\u00e9bora","family":"Reste-Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8447-9255","authenticated-orcid":false,"given":"Ant\u00f3nio","family":"Martinho","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Pereira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-6997","authenticated-orcid":false,"given":"In\u00eas","family":"Marques","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-7711","authenticated-orcid":false,"given":"Concei\u00e7\u00e3o","family":"Lobo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-9850","authenticated-orcid":false,"given":"Jos\u00e9","family":"Cunha-Vaz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1179_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels. 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK581934\/"},{"key":"1179_CR2","unstructured":"ETDRS. Early Treatment Diabetic Retinopathy Study (ETDRS): Manual of Operations. National Technical Reports Library; 1991."},{"key":"1179_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/eye.2009.108","volume":"23","author":"TM Curtis","year":"2009","unstructured":"Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye. 2009;23:1496\u2013508.","journal-title":"Eye"},{"key":"1179_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2337\/diab.12.4.293","volume":"12","author":"DG Cogan","year":"1963","unstructured":"Cogan DG, Kuwabara T. Capillary shunts in the pathogenesis of diabetic retinopathy. Diabetes. 1963;12:293\u2013300.","journal-title":"Diabetes"},{"key":"1179_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2337\/dc12-1491","volume":"36","author":"ML Ribeiro","year":"2013","unstructured":"Ribeiro ML, Nunes SG, Cunha-Vaz JG. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. Diabetes Care. 2013;36:1254\u20139.","journal-title":"Diabetes Care"},{"key":"1179_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/medicina59030435","volume":"59","author":"Y Takamura","year":"2023","unstructured":"Takamura Y, Yamada Y, Inatani M. Role of microaneurysms in the pathogenesis and therapy of diabetic macular edema: a descriptive review. Medicina (Kaunas). 2023;59:435.","journal-title":"Medicina (Kaunas)"},{"key":"1179_CR7","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1001\/archopht.1989.01070020862028","volume":"107","author":"R Klein","year":"1989","unstructured":"Klein R. The relationship of retinal microaneurysm counts to the 4-year progression of diabetic retinopathy. Arch Ophthalmol. 1989;107:1780.","journal-title":"Arch Ophthalmol"},{"key":"1179_CR8","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3390\/jcm10102142","volume":"10","author":"AR Santos","year":"2021","unstructured":"Santos AR, Mendes L, Madeira MH, Marques IP, Tavares D, Figueira J, et al. Microaneurysm turnover in mild non-proliferative diabetic retinopathy is associated with progression and development of vision-threatening complications: a 5-year longitudinal study. J Clin Med. 2021;10:2142.","journal-title":"J Clin Med"},{"key":"1179_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2337\/dc12-1491","volume":"36","author":"ML Ribeiro","year":"2013","unstructured":"Ribeiro ML, Nunes SG, Cunha-Vaz JG. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. Diabetes Care. 2013;36:1254\u20139.","journal-title":"Diabetes Care"},{"key":"1179_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1464-5491.2010.03210.x","volume":"28","author":"AK Sj\u00f8lie","year":"2011","unstructured":"Sj\u00f8lie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, et al. Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabetic Med. 2011;28:345\u201351.","journal-title":"Diabetic Med"},{"key":"1179_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1167\/iovs.13-13122","volume":"55","author":"M Dubow","year":"2014","unstructured":"Dubow M, Pinhas A, Shah N, Cooper RF, Gan A, Gentile RC, et al. Classification of human retinal microaneurysms using adaptive optics scanning light ophthalmoscope fluorescein angiography. Invest Ophthalmol Vis Sci. 2014;55:1299\u2013309.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1179_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.64.13.31","volume":"64","author":"Y Takamura","year":"2023","unstructured":"Takamura Y, Yamada Y, Morioka M, Gozawa M, Matsumura T, Inatani M. Turnover of microaneurysms after intravitreal injections of faricimab for diabetic macular edema. Invest Ophthalmol Vis Sci. 2023;64:31.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1179_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.oret.2020.06.010","volume":"4","author":"JF Russell","year":"2020","unstructured":"Russell JF, Shi Y, Scott NL, Gregori G, Rosenfeld PJ. Longitudinal angiographic evidence that intraretinal microvascular abnormalities can evolve into neovascularization. Ophthalmol Retina. 2020;4:1146\u201350.","journal-title":"Ophthalmol Retina"},{"key":"1179_CR14","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s40123-024-01054-2","volume":"13","author":"AR Santos","year":"2024","unstructured":"Santos AR, Lopes M, Santos T, Reste-Ferreira D, Marques IP, Yamaguchi TCN, et al. Intraretinal microvascular abnormalities in eyes with advanced stages of nonproliferative diabetic retinopathy: comparison between UWF-FFA, CFP, and OCTA\u2014the RICHARD study. Ophthalmol Ther. 2024;13:3161\u201373.","journal-title":"Ophthalmol Ther"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01179-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01179-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01179-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:16:44Z","timestamp":1757204204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01179-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01179-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lu\u00eds Mendes, Ana Rocha, Marta Lopes, Ana Almeida, Nicole Duarte, D\u00e9bora Reste-Ferreira, Ant\u00f3nio Martinho, Pedro Pereira, In\u00eas Marques, and Concei\u00e7\u00e3o Lobo declare there are no conflicts of interest. Pedro Pereira was a Retmarker employee. Jos\u00e9 Cunha-Vaz reports grants from Bayer, Boehringer Ingelheim and Carl Zeiss Meditec and is a consultant for Alimera Sciences, Bayer, Boehringer Ingelheim, Carl Zeiss Meditec and Roche. Jos\u00e9 Cunha-Vaz is an Editorial Board member of Ophthalmology and Therapy. Jos\u00e9 Cunha-Vaz was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The tenets of the Declaration of Helsinki were followed, and approval was obtained from the AIBILI Ethics Committee for Health with the number CEC\/009\/17- EYEMARKER. Written informed consent was obtained by each participant agreeing to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}